To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ARHGAP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
382 supporting clones for gene ARHGAP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA178841 amygdala .a 1 to 444 2 to 445   tiling clone, capped   444/451
(98 %)
1 diff
(99.8 %id)
BF882018 lung_tumor .a 5 to 539 13 to 547       535/548
(97 %)
2 diff
(99.7 %id)
DN999996   .a 8 to 675 8 to 675   tiling clone,   668/675
(98 %)
1 diff
(99.9 %id)
CN430390 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 16 to 680 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
CN430397 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 18 to 704 9 to 695       687/695
(98 %)
1 diff
(99.9 %id)
BG419553 Kidney, renal cell adenocarcinoma .a 18 to 754 15 to 748   tiling clone,   734/792
(92 %)
20 diff
(97.5 %id)
BG036896 brain, hippocampus .a 29 to 696 1 to 667       667/788
(84 %)
7 diff
(99.2 %id)
BI462936 testis .a 36 to 726 1 to 688       688/688
(100 %)
9 diff
(98.7 %id)
CB960915 Human Placenta, placenta .a 40 to 783 17 to 769       753/778
(96 %)
12 diff
(98.5 %id)
DA656481   .a 49 to 627 2 to 580   capped   579/580
(99 %)
2 diff
(99.7 %id)
CN430393 embryonic stem cells, DMSO-treated H9 cellline .a 51 to 803 1 to 754       754/754
(100 %)
7 diff
(99.1 %id)
BG720475 testis .a 52 to 547 1 to 496       496/498
(99 %)
7 diff
(98.6 %id)
CN430400 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 54 to 706 5 to 657       653/657
(99 %)
6 diff
(99.1 %id)
AL546584 placenta, Placenta Cot 25-normalized .a 57 to 901 1 to 845       845/982
(86 %)
10 diff
(99.0 %id)
BX364907 Placenta Cot 25-normalized .a 57 to 1062 1 to 1003       1003/1089
(92 %)
12 diff
(98.9 %id)
BI917631 brain .a 57 to 606 1 to 552       552/553
(99 %)
4 diff
(99.3 %id)
TI_57243795   .a 57 to 606 33 to 584       552/585
(94 %)
4 diff
(99.4 %id)
CN430399 embryonic stem cells, cell lines H1, H7, andH9 .a 60 to 594 1 to 535       535/535
(100 %)
1 diff
(99.9 %id)
BF972542 leiomyosarcoma cell line, uterus .a 60 to 791 1 to 736       736/821
(89 %)
21 diff
(97.5 %id)
Z23024 Fibrosarcoma .a 61 to 1490 1 to 1430 exact     1430/1430
(100 %)
1 diff
(100.0 %id)
CN430396 embryonic stem cells, cell lines H1, H7, andH9 .a 62 to 762 1 to 703       703/703
(100 %)
6 diff
(99.2 %id)
BM480080 duodenal adenocarcinoma, cell line, small intestine .a 62 to 820 1 to 758       758/1021
(74 %)
7 diff
(99.4 %id)
BF797848 lymph, lymphoma, cell line .a 68 to 791 1 to 731       731/775
(94 %)
11 diff
(98.6 %id)
BP356766 mammary gland .a 72 to 654 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
CO249729 Chondrosarcoma Lung Metastasis cell lines, lung .a 75 to 805 4 to 730       727/815
(89 %)
16 diff
(98.1 %id)
BM012403 brain, neuroblastoma, cell line .a 76 to 778 1 to 705       705/705
(100 %)
8 diff
(98.9 %id)
TI_59381615   .a 77 to 778 65 to 768       704/704
(100 %)
7 diff
(99.1 %id)
BQ953734 brain, neuroblastoma, cell line .a 79 to 901 1 to 829       829/863
(96 %)
11 diff
(98.8 %id)
DA702814   .a 79 to 564 2 to 487   capped   486/486
(100 %)
1 diff
(99.8 %id)
BM150316 leukopheresis .a 79 to 749 1 to 671       671/671
(100 %)
4 diff
(99.5 %id)
BM194587 leukopheresis .a 79 to 609 1 to 532       532/543
(97 %)
9 diff
(98.4 %id)
CO247343 Chondrosarcoma Lung Metastasis cell lines, lung .a 83 to 862 1 to 765       765/835
(91 %)
25 diff
(97.1 %id)
U02570   .a 88 to 3432 1 to 3345 exact     3345/3345
(100 %)
2 diff
(100.0 %id)
BC018118 Pancreas, epithelioid carcinoma .a 90 to 3431 1 to 3342 exact tiling clone, available from MGC, AAA   3342/3342
(100 %)
2 diff
(100.0 %id)
NM_004308.2   .a 90 to 3431 1 to 3342 exact RefSeq, AAA   3342/3342
(100 %)
2 diff
(100.0 %id)
BM721831 eye, fetal eye .a 90 to 611 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BU859193 ovary, teratocarcinoma, cell line .a 91 to 959 1 to 880       880/908
(96 %)
14 diff
(98.5 %id)
BI256160 cervical carcinoma cell line, cervix .a 95 to 728 1 to 654       654/786
(83 %)
39 diff
(95.1 %id)
CN430388 embryonic stem cells, cell lines H1, H7, andH9 .a 98 to 813 1 to 717       717/717
(100 %)
4 diff
(99.5 %id)
BM449807 melanotic melanoma, skin .a 104 to 801 1 to 696       696/930
(74 %)
18 diff
(98.1 %id)
CD300285 testis .a 104 to 957 22 to 877       856/878
(97 %)
9 diff
(99.0 %id)
DN999433   .a 109 to 711 12 to 614       604/614
(98 %)
1 diff
(99.9 %id)
BE904052 epithelioid carcinoma, Pancreas .a 111 to 801 1 to 688       688/699
(98 %)
11 diff
(98.5 %id)
CN430386 embryonic stem cells, DMSO-treated H9 cellline .a 127 to 532 1 to 406       406/406
(100 %)
1 diff
(99.8 %id)
CN430395 embryonic stem cells, cell lines H1, H7, andH9 .a 128 to 694 1 to 567       567/572
(99 %)
2 diff
(99.7 %id)
TI_1948129610   .a 153 to 867 125 to 838       714/1081
(66 %)
19 diff
(98.3 %id)
TI_1948129611   .a 153 to 694 119 to 659       541/1355
(39 %)
11 diff
(99.2 %id)
CV023204 mixed .a 159 to 793 1 to 635       635/640
(99 %)
3 diff
(99.6 %id)
CN430387 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 163 to 813 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
BF810961 colon_ins .a 198 to 562 1 to 364       364/432
(84 %)
12 diff
(97.3 %id)
BE720192 head_neck .a 266 to 477 15 to 226       212/232
(91 %)
2 diff
(99.2 %id)
BE711457 head_neck .a 325 to 679 1 to 363       359/363
(98 %)
13 diff
(96.5 %id)
BQ351627 head_neck .a 353 to 678 47 to 372       322/372
(86 %)
9 diff
(97.6 %id)
CN430391 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 386 to 1004 11 to 631       623/631
(98 %)
3 diff
(99.6 %id)
CO395412 Chondrosarcoma Lung Metastasis cell lines, lung .a 414 to 1034 1 to 612       614/741
(82 %)
33 diff
(95.6 %id)
BE711470 head_neck .a 452 to 793 345 to 4       342/345
(99 %)
1 diff
(99.8 %id)
BQ229570 melanotic melanoma, skin .a 480 to 876 1 to 404       404/947
(42 %)
11 diff
(98.9 %id)
AL600078   .a 500 to 793 1 to 294       294/298
(98 %)
8 diff
(97.4 %id)
CF125414 Chondrosarcoma Lung Metastasis cell lines, lung .a 511 to 1067 1 to 558       558/558
(100 %)
8 diff
(98.6 %id)
TI_154187159   .a 511 to 1057 49 to 595       547/726
(75 %)
8 diff
(98.9 %id)
BQ351629 head_neck .a 514 to 793 283 to 4       280/283
(98 %)
4 diff
(98.6 %id)
CF125833 Chondrosarcoma Lung Metastasis cell lines, lung .a 603 to 884 1 to 283       283/283
(100 %)
11 diff
(96.2 %id)
CF125973 Chondrosarcoma Lung Metastasis cell lines, lung .a 603 to 978 1 to 376       376/381
(98 %)
7 diff
(98.2 %id)
TI_154187453   .a 603 to 1193 123 to 712       590/917
(64 %)
38 diff
(95.9 %id)
BE834580 prostate_normal .a 604 to 842 242 to 4       239/251
(95 %)
7 diff
(97.3 %id)
BQ371113 prostate_normal .a 604 to 830 230 to 3       228/239
(95 %)
9 diff
(96.3 %id)
AA578186 bone marrow, stem cells .a 604 to 872 270 to 2       269/288
(93 %)
2 diff
(99.4 %id)
BM986735 mixed .a 607 to 1093 528 to 42   AAA   487/511
(95 %)
1 diff
(99.9 %id)
CO245172 Chondrosarcoma Lung Metastasis cell lines, lung .a 620 to 1185 1 to 566       566/768
(73 %)
6 diff
(99.3 %id)
BE540480 cervix .a 636 to 811 1 to 176       176/177
(99 %)
1 diff
(99.5 %id)
CN430385 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 660 to 1169 1 to 510       510/510
(100 %)
2 diff
(99.7 %id)
CO249905 Chondrosarcoma Lung Metastasis cell lines, lung .a 660 to 1182 8 to 521       514/686
(74 %)
24 diff
(96.6 %id)
EC563039 Prostate .a 673 to 754 87 to 4       84/87
(96 %)
0 diff
(100 %id)
BQ229167 embryonal carcinoma, cell line, testis .a 675 to 1511 1 to 847       847/877
(96 %)
20 diff
(97.8 %id)
BX410285 adult brain, brain .a 693 to 1433 1 to 742       742/785
(94 %)
7 diff
(99.2 %id)
BM904879 melanotic melanoma, skin .a 701 to 1694 11 to 1023       1013/1023
(99 %)
30 diff
(97.1 %id)
CO249147 Chondrosarcoma Lung Metastasis cell lines, lung .a 704 to 1416 8 to 714       707/815
(86 %)
14 diff
(98.3 %id)
BG396817 eye, retinoblastoma .a 709 to 1473 1 to 759       721/879
(82 %)
74 diff
(91.6 %id)
AL553827 placenta, Placenta Cot 25-normalized .a 720 to 1595 1 to 870       870/870
(100 %)
39 diff
(95.6 %id)
EC496306 Prostate .a 839 to 940 100 to 1       100/101
(99 %)
2 diff
(98.1 %id)
BQ431598 melanotic melanoma, skin .a 920 to 1564 1 to 649       649/949
(68 %)
8 diff
(99.2 %id)
AW610243 stomach .a 944 to 1246 304 to 2       303/304
(99 %)
1 diff
(99.7 %id)
TI_1948129612   .a 974 to 1477 637 to 133       487/1100
(44 %)
10 diff
(99.1 %id)
BE871909 adenocarcinoma, colon .a 981 to 1479 9 to 521       513/1083
(47 %)
31 diff
(97.2 %id)
BG164353 hypernephroma, cell line, Kidney .a 1017 to 1789 1 to 774       774/968
(79 %)
36 diff
(96.3 %id)
BI253232 cervical carcinoma cell line, cervix .a 1030 to 1821 13 to 810       798/860
(92 %)
33 diff
(96.2 %id)
CT001556 T-Lymphocytes .a 1054 to 1880 1 to 828       828/828
(100 %)
2 diff
(99.8 %id)
BF943093 nervous_normal .a 1067 to 1574 30 to 537       508/537
(94 %)
3 diff
(99.5 %id)
BU169971 embryonal carcinoma, cell line, testis .a 1119 to 1964 1 to 859       859/863
(99 %)
18 diff
(98.0 %id)
R84525 brain .a 1126 to 1606 1 to 484       484/490
(98 %)
13 diff
(97.4 %id)
H41487 brain .a 1128 to 1471 1 to 344       344/344
(100 %)
6 diff
(98.3 %id)
BM807506 amelanotic melanoma, cell line, skin .a 1186 to 1839 1 to 656       656/1172
(55 %)
12 diff
(99.0 %id)
AA776084 schizophrenic brain S-11 frontal lobe .a 1212 to 1436 1 to 225     Submitted on the opposite strand 225/225
(100 %)
3 diff
(98.7 %id)
AW863802 stomach_normal .a 1213 to 1790 586 to 1       586/622
(94 %)
41 diff
(93.5 %id)
BQ687612 ductal carcinoma, cell line, Pancreas .a 1287 to 2165 1 to 883       883/900
(98 %)
14 diff
(98.5 %id)
BQ641459 eye, normal pigmented retinal epithelium .a 1289 to 2150 10 to 888       879/935
(94 %)
30 diff
(96.8 %id)
BM050412 eye, normal pigmented retinal epithelium .a 1298 to 1934 1 to 638       638/639
(99 %)
10 diff
(98.5 %id)
BE797727 lung, small cell carcinoma .a 1324 to 1965 47 to 679       633/683
(92 %)
11 diff
(98.4 %id)
BU193874 leiomyosarcoma, uterus .a 1326 to 2060 1 to 737       737/938
(78 %)
6 diff
(99.4 %id)
BG110621 Bone, osteosarcoma, cell line .a 1451 to 2239 1 to 790       790/828
(95 %)
29 diff
(96.5 %id)
AJ707634 heart .a 1524 to 2029 1 to 506       506/532
(95 %)
3 diff
(99.5 %id)
BE274275 melanotic melanoma, skin .a 1565 to 2221 1 to 659       659/661
(99 %)
5 diff
(99.3 %id)
BG392814 embryonal carcinoma, cell line, testis .a 1565 to 2310 1 to 744       744/971
(76 %)
18 diff
(98.2 %id)
BE727526 melanotic melanoma, skin .a 1567 to 2228 1 to 703       703/705
(99 %)
11 diff
(98.5 %id)
AA180398 brain, neuroepithelial cells .a 1599 to 2004 1 to 411       411/411
(100 %)
9 diff
(97.9 %id)
BE887533 leiomyosarcoma, uterus .a 1601 to 2310 1 to 702       702/731
(96 %)
13 diff
(98.3 %id)
BF966197 brain, hippocampus .a 1607 to 2337 1 to 726       726/863
(84 %)
6 diff
(99.4 %id)
BU859559 ovary, teratocarcinoma, cell line .a 1611 to 2337 1 to 734       734/901
(81 %)
20 diff
(97.8 %id)
DA052307   .a 1635 to 2240 2 to 607   capped   606/606
(100 %)
2 diff
(99.7 %id)
DA254203 caudate nucleus .a 1635 to 2200 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA262602 caudate nucleus .a 1635 to 2207 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA288000 corpus callosum .a 1635 to 2164 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
BX487234   .a 1637 to 2254 21 to 638       618/638
(96 %)
0 diff
(100 %id)
BP253003 Kidney .a 1664 to 2246 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BU178213 melanotic melanoma, skin .a 1696 to 2447 1 to 758       758/843
(89 %)
10 diff
(98.9 %id)
DA614500   .a 1706 to 2273 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
BG955693 colon .a 1727 to 1969 8 to 250       243/252
(96 %)
13 diff
(94.9 %id)
DA668281 esophagus .a 1782 to 2267 2 to 487   capped   486/486
(100 %)
3 diff
(99.4 %id)
AA207230   .a 1800 to 2275 1 to 478       478/519
(92 %)
17 diff
(96.8 %id)
BF971692 leiomyosarcoma cell line, uterus .a 1801 to 2566 1 to 762       762/832
(91 %)
19 diff
(97.8 %id)
DA365436 subthalamic nucleus .a 1823 to 2294 2 to 473   capped   472/472
(100 %)
1 diff
(99.8 %id)
BM041285 Kidney, Wilms' tumor, cell line .a 1839 to 2567 1 to 725       725/896
(80 %)
16 diff
(98.3 %id)
BF337888 brain, glioblastoma with EGFR amplification .a 1851 to 2549 1 to 691       691/922
(74 %)
12 diff
(98.7 %id)
BX433467 adult brain, brain .a 1860 to 2756 908 to 14       895/960
(93 %)
0 diff
(100 %id)
BG696049 skin .a 1886 to 2683 1 to 800       800/973
(82 %)
12 diff
(98.8 %id)
BQ671698 epidermoid carcinoma, cell line, salivary gland .a 1915 to 2267 1 to 353       353/353
(100 %)
0 diff
(100 %id)
BG485433 lung .a 1933 to 2535 1 to 614       614/1040
(59 %)
11 diff
(99.0 %id)
BF884221 lung_tumor .a 1936 to 2326 391 to 1     Submitted on the opposite strand 391/391
(100 %)
0 diff
(100 %id)
CO246623 Chondrosarcoma Lung Metastasis cell lines, lung .a 1948 to 2495 8 to 556       549/740
(74 %)
18 diff
(97.6 %id)
BF950725 nervous_normal .a 1952 to 2233 290 to 2       289/290
(99 %)
0 diff
(100 %id)
BF951450 nervous_normal .a 1952 to 2233 290 to 2       289/290
(99 %)
0 diff
(100 %id)
BP253776 Kidney .a 1963 to 2543 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BE836796 prostate_normal .a 1967 to 2326 8 to 366       359/374
(95 %)
5 diff
(98.7 %id)
BF525558 brain, glioblastoma with EGFR amplification .a 2007 to 2716 1 to 701       701/896
(78 %)
8 diff
(99.2 %id)
BE717271 head_neck .a 2010 to 2326 11 to 326       316/335
(94 %)
3 diff
(99.2 %id)
CD558617 White Matter .a 2065 to 2885 1 to 831       831/894
(92 %)
28 diff
(96.9 %id)
AW884989 ovary .a 2109 to 2493 392 to 9       384/392
(97 %)
0 diff
(100 %id)
BX097839 whole brain .a 2126 to 2633 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
BG740427 skin .a 2147 to 2576 1 to 433       433/804
(53 %)
6 diff
(99.3 %id)
CO398606 Chondrosarcoma Lung Metastasis cell lines, lung .a 2149 to 2863 46 to 753       708/873
(81 %)
12 diff
(98.7 %id)
CX781055 human embryonic stem cells .a 2161 to 2939 1 to 779       779/779
(100 %)
1 diff
(99.9 %id)
BF858150 prostate_tumor .a 2185 to 2522 338 to 1     Submitted on the opposite strand 338/338
(100 %)
4 diff
(98.9 %id)
H09711 whole brain .a 2188 to 2533 1 to 352       352/380
(92 %)
7 diff
(98.2 %id)
BF528276 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2212 to 2959 1 to 746       746/774
(96 %)
13 diff
(98.4 %id)
CF134873 CNCAP(3)T-225 cell line, Prostate .a 2214 to 2609 1 to 394       394/394
(100 %)
6 diff
(98.5 %id)
TI_154162982   .a 2221 to 2913 80 to 791       712/766
(92 %)
35 diff
(95.5 %id)
BQ921956 leiomyosarcoma, uterus .a 2301 to 3215 1 to 923       923/923
(100 %)
25 diff
(97.3 %id)
N27039 melanocyte .a 2323 to 2677 1 to 352       352/352
(100 %)
3 diff
(99.2 %id)
CO248288 Chondrosarcoma Lung Metastasis cell lines, lung .a 2340 to 3048 8 to 715       708/799
(88 %)
11 diff
(98.7 %id)
BE544353 cervical carcinoma cell line, cervix .a 2341 to 3069 1 to 731       731/823
(88 %)
43 diff
(94.8 %id)
BX364906 Placenta Cot 25-normalized .a 2355 to 3372 1011 to 1       1011/1093
(92 %)
15 diff
(98.7 %id)
CN430392 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2381 to 2877 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
BM510438 insulinoma, Pancreas .a 2386 to 2864 8 to 486       479/486
(98 %)
0 diff
(100 %id)
AL546737 placenta, Placenta Cot 25-normalized .a 2392 to 3403 1004 to 1       1004/1004
(100 %)
20 diff
(98.1 %id)
BE386570 melanotic melanoma, skin .a 2407 to 2895 1 to 495       495/495
(100 %)
21 diff
(95.8 %id)
AL120976 melanoma (MeWo cell line) .a 2432 to 2947 1 to 515       515/516
(99 %)
3 diff
(99.5 %id)
R92262 liver and spleen .a 2448 to 2904 1 to 460       460/462
(99 %)
10 diff
(97.9 %id)
AL533379 adult brain, brain .a 2490 to 3406 920 to 5       916/920
(99 %)
0 diff
(100 %id)
BE891671 melanotic melanoma, skin .a 2549 to 3275 1 to 732       732/925
(79 %)
27 diff
(97.1 %id)
CN430398 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2556 to 3151 31 to 626       596/626
(95 %)
0 diff
(100 %id)
AL576717 placenta, Placenta Cot 25-normalized .a 2558 to 3379 830 to 11       820/830
(98 %)
0 diff
(100 %id)
BI226515 Burkitt lymphoma, lymph .a 2558 to 3382 33 to 876       844/936
(90 %)
55 diff
(94.2 %id)
AA226861 brain, neuroepithelial cells .a 2569 to 3067 1 to 495   fully sequenced,   495/495
(100 %)
10 diff
(98.0 %id)
BM352564 Pancreas, Purified pancreatic islet .a 2570 to 3066 1 to 497     Submitted on the opposite strand 497/497
(100 %)
2 diff
(99.6 %id)
AA218577 brain, neuroepithelial cells .a 2570 to 2788 1 to 219       219/219
(100 %)
0 diff
(100 %id)
CA776344 Pancreas, Purified pancreatic islet .a 2571 to 3176 1 to 606     Submitted on the opposite strand 606/606
(100 %)
1 diff
(99.9 %id)
CA776495 Pancreas, Purified pancreatic islet .a 2571 to 2961 1 to 391   fully sequenced, Submitted on the opposite strand 391/391
(100 %)
1 diff
(99.8 %id)
BM503237 Pancreas, Purified pancreatic islet .a 2572 to 3168 1 to 597     Submitted on the opposite strand 597/597
(100 %)
1 diff
(99.9 %id)
T40799 fetal spleen, Spleen .a 2572 to 2910 1 to 338     Submitted on the opposite strand 338/338
(100 %)
4 diff
(98.9 %id)
CD216768 lung .a 2575 to 2964 390 to 1     Submitted on the opposite strand 390/390
(100 %)
1 diff
(99.8 %id)
BM556588 duodenal adenocarcinoma, cell line, small intestine .a 2584 to 3430 13 to 880       868/985
(88 %)
33 diff
(96.7 %id)
TI_154030983   .a 2637 to 3438 827 to 23   AAA   805/809
(99 %)
58 diff
(92.9 %id)
TI_154128885   .a 2642 to 3431 866 to 94   AAA   773/934
(82 %)
22 diff
(97.7 %id)
BQ876411 sympathetic trunk .a 2649 to 3443 1 to 799       799/916
(87 %)
41 diff
(95.6 %id)
BF966854 brain, hippocampus .a 2653 to 3390 767 to 23       745/1043
(71 %)
0 diff
(100 %id)
BP419174 small intestine .a 2661 to 3016 164 to 519     Submitted on the opposite strand 356/519
(68 %)
0 diff
(100 %id)
BF910872 uterus_tumor .a 2670 to 2904 8 to 243       236/244
(96 %)
6 diff
(97.6 %id)
CD370332 Alveolar Macrophage, lung .a 2681 to 3431 765 to 19   AAA   747/747
(100 %)
5 diff
(99.4 %id)
BU616250 Bone, Subchondral Bone .a 2687 to 3431 761 to 19   AAA   743/743
(100 %)
5 diff
(99.4 %id)
BY997519   .a 2699 to 3367 22 to 690       669/690
(96 %)
0 diff
(100 %id)
AI002859   .a 2706 to 3425 718 to 1       718/718
(100 %)
103 diff
(85.7 %id)
H44216 brain .a 2712 to 3084 1 to 374       374/374
(100 %)
6 diff
(98.4 %id)
BM990742 lung, Lung Focal Fibrosis .a 2715 to 3409 6 to 700     Submitted on the opposite strand 695/700
(99 %)
0 diff
(100 %id)
BM876429 insulinoma, Pancreas .a 2717 to 3053 3 to 339   fully sequenced,   337/339
(99 %)
6 diff
(98.3 %id)
BM876440 insulinoma, Pancreas .a 2717 to 3183 3 to 469   fully sequenced,   467/469
(99 %)
6 diff
(98.8 %id)
BM894522 insulinoma, Pancreas .a 2717 to 3036 3 to 322   fully sequenced,   320/322
(99 %)
6 diff
(98.2 %id)
BQ128110 insulinoma, Pancreas .a 2717 to 3053 3 to 339   fully sequenced,   337/339
(99 %)
6 diff
(98.3 %id)
BQ268161 insulinoma, Pancreas .a 2717 to 3014 3 to 300   fully sequenced,   298/300
(99 %)
6 diff
(98.0 %id)
BQ268212 insulinoma, Pancreas .a 2717 to 3053 3 to 339   fully sequenced,   337/339
(99 %)
6 diff
(98.3 %id)
BQ787431 insulinoma, Pancreas .a 2717 to 3030 3 to 316   fully sequenced,   314/316
(99 %)
6 diff
(98.2 %id)
BU077842 insulinoma, Pancreas .a 2717 to 3014 3 to 300   fully sequenced,   298/300
(99 %)
6 diff
(98.0 %id)
BU787965 insulinoma, Pancreas .a 2717 to 3030 3 to 317   fully sequenced,   315/317
(99 %)
6 diff
(98.2 %id)
BI710963 insulinoma, Pancreas .a 2722 to 3139 8 to 425       418/429
(97 %)
3 diff
(99.4 %id)
BQ130377 insulinoma, Pancreas .a 2722 to 3254 8 to 540       533/540
(98 %)
0 diff
(100 %id)
BQ787777 insulinoma, Pancreas .a 2722 to 2968 8 to 254       247/254
(97 %)
0 diff
(100 %id)
BU071850 insulinoma, Pancreas .a 2722 to 3277 8 to 563       556/563
(98 %)
0 diff
(100 %id)
AA443506 ovarian tumor, ovary .a 2727 to 3055 1 to 318   fully sequenced,   318/318
(100 %)
4 diff
(98.8 %id)
H44170 brain .a 2730 to 3093 1 to 369   fully sequenced,   369/369
(100 %)
18 diff
(95.2 %id)
R73163 breast .a 2736 to 3089 1 to 355       355/362
(98 %)
7 diff
(98.1 %id)
AI961929 adenocarcinoma, Pancreas .a 2766 to 3435 669 to 1       669/669
(100 %)
21 diff
(96.9 %id)
AI926607 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2788 to 3432 643 to 1       643/643
(100 %)
10 diff
(98.5 %id)
BQ005767 Chondrosarcoma, Left Pubic Bone .a 2788 to 3431 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
BQ027035 Chondrosarcoma, Left Pubic Bone .a 2789 to 3431 660 to 19   AAA   642/642
(100 %)
3 diff
(99.6 %id)
AA622625 lung, lung tumor .a 2791 to 3435 649 to 5       645/649
(99 %)
0 diff
(100 %id)
BG468434 adenocarcinoma cell line, colon .a 2796 to 3440 1 to 646       646/894
(72 %)
4 diff
(99.6 %id)
BG468524 adenocarcinoma cell line, colon .a 2796 to 3438 1 to 643   AAA   643/643
(100 %)
2 diff
(99.7 %id)
AW055231 brain, glioblastoma (pooled) .a 2802 to 3438 639 to 2       638/644
(99 %)
0 diff
(100 %id)
AW152101 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2802 to 3435 635 to 2       634/635
(99 %)
0 diff
(100 %id)
BF736860 bladder_tumor .a 2812 to 2979 184 to 20     Submitted on the opposite strand 165/195
(84 %)
0 diff
(100 %id)
BG687537 lung, mucoepidermoid carcinoma .a 2812 to 3420 1 to 613       613/615
(99 %)
11 diff
(98.3 %id)
AW275912 lung, two pooled squamous cell carcinomas .a 2813 to 3435 625 to 3       623/625
(99 %)
0 diff
(100 %id)
CA417795 Chondrosarcoma Cell line .a 2814 to 3431 636 to 19   AAA   618/618
(100 %)
1 diff
(99.9 %id)
BE675582 B-cell, chronic lymphotic leukemia .a 2815 to 3433 619 to 1       619/623
(99 %)
23 diff
(96.4 %id)
BQ182091 Knee, Osteoarthritic Cartilage .a 2819 to 3431 631 to 19   AAA   613/613
(100 %)
1 diff
(99.9 %id)
BM681970 eye, fetal eye .a 2819 to 3438 638 to 19   AAA   620/620
(100 %)
1 diff
(99.9 %id)
BQ020361 Chondrosarcoma, Left Pubic Bone .a 2828 to 3431 622 to 19   AAA   604/604
(100 %)
2 diff
(99.7 %id)
R22264 placenta .a 2830 to 3047 8 to 229       222/229
(96 %)
0 diff
(100 %id)
AW959636   .a 2835 to 3430 596 to 1     Submitted on the opposite strand 596/600
(99 %)
35 diff
(94.2 %id)
EB388896 eye, optic nerve .a 2839 to 3439 631 to 31   AAA Submitted on the opposite strand 601/604
(99 %)
10 diff
(98.4 %id)
AI911919 adenocarcinoma, Pancreas .a 2841 to 3431 604 to 16   AAA   589/595
(98 %)
23 diff
(96.2 %id)
BF842524 head_neck .a 2843 to 3178 375 to 38     Submitted on the opposite strand 338/375
(90 %)
0 diff
(100 %id)
AI684106 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2845 to 3431 601 to 16   AAA   586/586
(100 %)
43 diff
(92.7 %id)
AW166109 brain, medulloblastoma .a 2845 to 3431 616 to 27   AAA   590/591
(99 %)
0 diff
(100 %id)
AI828541 anaplastic oligodendroglioma, brain .a 2846 to 3360 517 to 1       517/517
(100 %)
19 diff
(96.4 %id)
CN430394 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2847 to 3431 1 to 584   AAA   584/584
(100 %)
6 diff
(99.0 %id)
AW029564 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2847 to 3431 586 to 1       586/586
(100 %)
6 diff
(99.0 %id)
AA873265 2 pooled tumors (clear cell type), Kidney .a 2849 to 3438 585 to 3       583/585
(99 %)
0 diff
(100 %id)
AW131504 brain, medulloblastoma .a 2850 to 3435 586 to 1       586/586
(100 %)
1 diff
(99.9 %id)
R63308 placenta .a 2851 to 3186 1 to 342   fully sequenced,   342/342
(100 %)
12 diff
(96.5 %id)
R63302 placenta .a 2852 to 3153 1 to 303   fully sequenced,   303/303
(100 %)
7 diff
(97.7 %id)
DB290359 uterus .a 2855 to 3435 2 to 582   capped   581/586
(99 %)
1 diff
(99.9 %id)
D53999   .a 2857 to 3089 42 to 275       234/275
(85 %)
0 diff
(100 %id)
AI206092 Kidney .a 2858 to 3431 585 to 19   AAA   567/567
(100 %)
11 diff
(98.1 %id)
T84686 liver and spleen .a 2863 to 3094 1 to 232   fully sequenced,   232/232
(100 %)
7 diff
(97.0 %id)
R16405 liver and spleen .a 2863 to 3190 1 to 338   fully sequenced,   338/338
(100 %)
6 diff
(98.3 %id)
AI885023 anaplastic oligodendroglioma, brain .a 2863 to 3430 569 to 1       569/569
(100 %)
29 diff
(95.0 %id)
AA130385 uterus .a 2864 to 3312 1 to 457       457/466
(98 %)
16 diff
(96.6 %id)
CB123874 Liver .a 2864 to 3242 379 to 1     Submitted on the opposite strand 379/379
(100 %)
0 diff
(100 %id)
AA129899 uterus .a 2870 to 3016 1 to 156   fully sequenced,   156/156
(100 %)
1 diff
(99.4 %id)
BM994321 lung, Metastatic Chondrosarcoma .a 2870 to 3431 580 to 19   AAA   562/562
(100 %)
1 diff
(99.9 %id)
AA034275 uterus .a 2871 to 3434 1 to 578       578/578
(100 %)
28 diff
(95.2 %id)
AA147479 uterus .a 2871 to 3249 1 to 381   fully sequenced,   381/381
(100 %)
6 diff
(98.5 %id)
AA780351   .a 2874 to 3340 468 to 1       468/468
(100 %)
5 diff
(99.0 %id)
W58667 heart .a 2886 to 3278 1 to 394   fully sequenced,   394/394
(100 %)
6 diff
(98.5 %id)
W45001 parathyroid gland, parathyroid tumor .a 2889 to 3198 1 to 316   fully sequenced,   316/316
(100 %)
9 diff
(97.2 %id)
AA374236 lung .a 2891 to 3213 1 to 323       323/323
(100 %)
1 diff
(99.7 %id)
AW963707   .a 2892 to 3421 1 to 531       531/531
(100 %)
8 diff
(98.5 %id)
AW024915 Kidney .a 2894 to 3431 560 to 24   AAA   537/537
(100 %)
20 diff
(96.3 %id)
AI265950   .a 2895 to 3431 547 to 16   AAA   532/541
(98 %)
10 diff
(98.2 %id)
AW974055   .a 2901 to 3431 531 to 1     Submitted on the opposite strand 531/532
(99 %)
17 diff
(96.9 %id)
AI862843 lymph node, lymphoma, follicular mixed small and largecell .a 2902 to 3431 545 to 16   AAA   530/548
(96 %)
14 diff
(97.5 %id)
AW130647 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2912 to 3435 528 to 5       524/528
(99 %)
0 diff
(100 %id)
AA553868 colon, tumor .a 2915 to 3435 513 to 1       513/513
(100 %)
38 diff
(92.6 %id)
AA216777 brain, neuroepithelial cells .a 2916 to 3435 528 to 3       526/530
(99 %)
0 diff
(100 %id)
BG288097 bladder, transitional cell papilloma, cell line .a 2918 to 3431 1 to 524   AAA   524/524
(100 %)
14 diff
(97.4 %id)
W76382 heart .a 2921 to 3127 1 to 207       207/211
(98 %)
5 diff
(97.7 %id)
BF871220 lung_tumor .a 2922 to 3317 5 to 400       396/407
(97 %)
6 diff
(98.6 %id)
AI499812 anaplastic oligodendroglioma, brain .a 2923 to 3435 507 to 4       504/507
(99 %)
0 diff
(100 %id)
R85916 brain .a 2927 to 3426 527 to 14       514/529
(97 %)
0 diff
(100 %id)
AI591210 brain, tumor, 5 pooled (see description) .a 2927 to 3435 509 to 3       507/519
(97 %)
0 diff
(100 %id)
BM503397 Pancreas, Purified pancreatic islet .a 2928 to 3438 542 to 32   AAA Submitted on the opposite strand 511/511
(100 %)
2 diff
(99.7 %id)
BM671747 eye, optic nerve .a 2928 to 3431 522 to 19   AAA   504/519
(97 %)
2 diff
(99.7 %id)
TI_151771929   .a 2928 to 3431 99 to 602       504/1088
(46 %)
7 diff
(99.4 %id)
AI589483 adenocarcinoma, Pancreas .a 2929 to 3438 515 to 7       509/515
(98 %)
0 diff
(100 %id)
H30129 breast .a 2930 to 3345 1 to 422       422/422
(100 %)
9 diff
(97.9 %id)
H43457 breast .a 2930 to 3252 1 to 331   fully sequenced,   331/331
(100 %)
3 diff
(99.1 %id)
CA776723 Pancreas, Purified pancreatic islet .a 2931 to 3186 256 to 1   fully sequenced, Submitted on the opposite strand 256/256
(100 %)
0 diff
(100 %id)
BP389471 pancreatic islet .a 2937 to 3435 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
BU782529 insulinoma, Pancreas .a 2939 to 3431 523 to 31   AAA   493/493
(100 %)
1 diff
(99.8 %id)
BU782534 insulinoma, Pancreas .a 2939 to 3431 524 to 32   AAA   493/493
(100 %)
1 diff
(99.8 %id)
BM149637 leukopheresis .a 2941 to 3431 507 to 17   AAA   491/491
(100 %)
0 diff
(100 %id)
AI567423 anaplastic oligodendroglioma, brain .a 2942 to 3435 495 to 2       494/495
(99 %)
0 diff
(100 %id)
BM708950 eye, RPE and Choroid .a 2944 to 3430 1 to 487   fully sequenced,   487/487
(100 %)
0 diff
(100 %id)
AI582132 colon .a 2948 to 3435 491 to 6       486/513
(94 %)
0 diff
(100 %id)
AI131074 heart .a 2949 to 3435 489 to 3       487/489
(99 %)
0 diff
(100 %id)
BI711158 insulinoma, Pancreas .a 2952 to 3431 510 to 31   AAA   480/480
(100 %)
0 diff
(100 %id)
BU740030 eye, fetal eye .a 2952 to 3431 498 to 19   AAA   480/480
(100 %)
0 diff
(100 %id)
AI934738 anaplastic oligodendroglioma, brain .a 2953 to 3435 483 to 1       483/483
(100 %)
2 diff
(99.6 %id)
CK905823 insulinoma, Pancreas .a 2956 to 3431 504 to 29   AAA   476/476
(100 %)
1 diff
(99.8 %id)
H46273 brain .a 2958 to 3413 462 to 1       462/466
(99 %)
10 diff
(97.9 %id)
BQ130127 insulinoma, Pancreas .a 2958 to 3431 503 to 30   AAA   474/474
(100 %)
2 diff
(99.6 %id)
BQ292242 amnion_normal .a 2959 to 3220 273 to 11       263/273
(96 %)
0 diff
(100 %id)
AA593675 breast .a 2960 to 3429 463 to 1       463/463
(100 %)
25 diff
(94.7 %id)
AA983163 2 pooled tumors (clear cell type), Kidney .a 2962 to 3435 481 to 6       476/481
(98 %)
0 diff
(100 %id)
BQ030393 lung, Metastatic Chondrosarcoma .a 2963 to 3431 487 to 19   AAA   469/469
(100 %)
0 diff
(100 %id)
AJ708554 heart .a 2965 to 3431 1 to 466   AAA   466/466
(100 %)
4 diff
(99.2 %id)
AI373387 uterus .a 2965 to 3435 469 to 1       469/469
(100 %)
17 diff
(96.4 %id)
AI826515 normal prostate, Prostate .a 2966 to 3435 470 to 1       470/470
(100 %)
0 diff
(100 %id)
BM511692 insulinoma, Pancreas .a 2977 to 3431 485 to 31   AAA   455/455
(100 %)
0 diff
(100 %id)
AI934501 anaplastic oligodendroglioma, brain .a 2979 to 3435 461 to 5       457/461
(99 %)
0 diff
(100 %id)
AI340166 2 pooled tumors (clear cell type), Kidney .a 2980 to 3431 471 to 20   AAA   452/452
(100 %)
2 diff
(99.6 %id)
AW169627 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2980 to 3435 456 to 3       454/456
(99 %)
0 diff
(100 %id)
BQ267905 insulinoma, Pancreas .a 2984 to 3431 478 to 31   fully sequenced, AAA   448/448
(100 %)
0 diff
(100 %id)
BU077641 insulinoma, Pancreas .a 2984 to 3431 478 to 31   fully sequenced, AAA   448/448
(100 %)
0 diff
(100 %id)
AI871375 anaplastic oligodendroglioma, brain .a 2985 to 3435 452 to 2       451/452
(99 %)
0 diff
(100 %id)
AW024626 Kidney .a 2985 to 3435 453 to 3       451/453
(99 %)
0 diff
(100 %id)
AA129900 uterus .a 2986 to 3435 464 to 1   fully sequenced,   464/464
(100 %)
13 diff
(97.2 %id)
AI083881 anaplastic oligodendroglioma, brain .a 2987 to 3435 452 to 4       449/452
(99 %)
0 diff
(100 %id)
AI829043 2 pooled tumors (clear cell type), Kidney .a 2990 to 3431 451 to 12   AAA   440/440
(100 %)
7 diff
(98.5 %id)
AI130913 heart .a 2994 to 3435 443 to 2       442/443
(99 %)
0 diff
(100 %id)
BM915945 amelanotic melanoma, cell line, skin .a 2997 to 3431 25 to 459   AAA   435/462
(94 %)
1 diff
(99.8 %id)
BU070416 insulinoma, Pancreas .a 3000 to 3431 460 to 29   fully sequenced, AAA   432/432
(100 %)
1 diff
(99.8 %id)
BU784301 insulinoma, Pancreas .a 3000 to 3431 461 to 30   fully sequenced, AAA   432/432
(100 %)
3 diff
(99.4 %id)
H99162 melanocyte .a 3002 to 3431 433 to 1       433/435
(99 %)
6 diff
(98.7 %id)
W96410 heart .a 3002 to 3388 432 to 42       391/432
(90 %)
0 diff
(100 %id)
BQ787591 insulinoma, Pancreas .a 3005 to 3431 454 to 28   AAA   427/427
(100 %)
2 diff
(99.6 %id)
BM894250 insulinoma, Pancreas .a 3006 to 3431 455 to 30   fully sequenced, AAA   426/426
(100 %)
0 diff
(100 %id)
AA706296   .a 3009 to 3433 426 to 1       426/426
(100 %)
9 diff
(97.9 %id)
AW340103 pooled .a 3021 to 3434 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
BM876170 insulinoma, Pancreas .a 3023 to 3431 439 to 31   fully sequenced, AAA   409/409
(100 %)
0 diff
(100 %id)
BQ128372 insulinoma, Pancreas .a 3023 to 3431 439 to 31   fully sequenced, AAA   409/409
(100 %)
0 diff
(100 %id)
BQ267942 insulinoma, Pancreas .a 3023 to 3431 439 to 31   fully sequenced, AAA   409/409
(100 %)
1 diff
(99.8 %id)
AA427934 ovarian tumor, ovary .a 3025 to 3431 433 to 27   fully sequenced, AAA   407/407
(100 %)
3 diff
(99.3 %id)
AI640658 adenocarcinoma, Pancreas .a 3036 to 3440 418 to 15   AAA   404/439
(92 %)
22 diff
(95.0 %id)
AJ574144 pectoral muscle (after mastectomy) .a 3040 to 3375 8 to 341       334/341
(97 %)
0 diff
(100 %id)
AJ346003 pectoral muscle (after mastectomy) .a 3041 to 3435 1 to 395       395/395
(100 %)
0 diff
(100 %id)
AJ346048 pectoral muscle (after mastectomy) .a 3041 to 3435 1 to 395       395/395
(100 %)
3 diff
(99.3 %id)
AI431257 aorta .a 3041 to 3431 452 to 62   AAA   391/391
(100 %)
1 diff
(99.8 %id)
AA678901   .a 3047 to 3431 393 to 17   AAA   377/377
(100 %)
14 diff
(96.3 %id)
AA770327   .a 3048 to 3433 385 to 1       385/385
(100 %)
2 diff
(99.5 %id)
AA227211 brain, neuroepithelial cells .a 3049 to 3435 388 to 3   fully sequenced,   386/388
(99 %)
0 diff
(100 %id)
BU615239 Bone, Human Chondrosarcoma Cell Line .a 3050 to 3431 400 to 19   AAA   382/382
(100 %)
2 diff
(99.5 %id)
AA507415 breast .a 3052 to 3430 382 to 1       382/443
(86 %)
14 diff
(96.9 %id)
H09666 whole brain .a 3054 to 3435 396 to 6       391/441
(88 %)
0 diff
(100 %id)
H42325 brain .a 3056 to 3430 376 to 3       374/376
(99 %)
0 diff
(100 %id)
T91177 liver and spleen .a 3064 to 3431 386 to 14   fully sequenced, AAA   373/373
(100 %)
10 diff
(97.4 %id)
AI933242 anaplastic oligodendroglioma, brain .a 3068 to 3435 367 to 2       366/367
(99 %)
0 diff
(100 %id)
AA032067.
matches multiple genes
uterus .a 3071 to 3435 376 to 1     also hits gene NOTCH2 376/385
(97 %)
13 diff
(96.7 %id)
AA219540 brain, neuroepithelial cells .a 3076 to 3435 363 to 3       361/363
(99 %)
0 diff
(100 %id)
H44082 brain .a 3079 to 3422 352 to 10   fully sequenced,   343/352
(97 %)
0 diff
(100 %id)
AI085100 senescent fibroblast .a 3081 to 3430 350 to 1       350/350
(100 %)
11 diff
(96.9 %id)
BY796987 eye .a 3092 to 3432 1 to 341       341/341
(100 %)
0 diff
(100 %id)
AW118563 brain, tumor, 5 pooled (see description) .a 3096 to 3440 357 to 11   AAA   347/347
(100 %)
4 diff
(98.9 %id)
AI915165 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3103 to 3431 338 to 12   AAA   327/327
(100 %)
3 diff
(99.1 %id)
R22211 placenta .a 3109 to 3429 340 to 19   AAA   322/324
(99 %)
0 diff
(100 %id)
AA923609 colon, colon tumor RER+ .a 3109 to 3431 323 to 1       323/323
(100 %)
4 diff
(98.8 %id)
BM988959 lung, Lung Focal Fibrosis .a 3115 to 3438 342 to 19   AAA   324/324
(100 %)
1 diff
(99.7 %id)
AA180399 brain, neuroepithelial cells .a 3130 to 3431 316 to 15   AAA   302/400
(75 %)
7 diff
(98.3 %id)
R63303 placenta .a 3136 to 3432 297 to 1   fully sequenced,   297/297
(100 %)
0 diff
(100 %id)
H44217 brain .a 3136 to 3420 285 to 1       285/285
(100 %)
0 diff
(100 %id)
AI918320 anaplastic oligodendroglioma, brain .a 3141 to 3435 294 to 2       293/298
(98 %)
0 diff
(100 %id)
R91934 liver and spleen .a 3145 to 3427 286 to 4       283/296
(95 %)
0 diff
(100 %id)
BM876179 insulinoma, Pancreas .a 3153 to 3431 309 to 31   fully sequenced, AAA   279/279
(100 %)
0 diff
(100 %id)
R63309 placenta .a 3156 to 3430 275 to 1   fully sequenced,   275/275
(100 %)
0 diff
(100 %id)
AA595231 breast .a 3158 to 3430 273 to 1       273/273
(100 %)
9 diff
(96.8 %id)
AA886654 Kidney .a 3158 to 3431 290 to 17   AAA   274/274
(100 %)
8 diff
(97.1 %id)
R12668 liver and spleen .a 3160 to 3431 285 to 13   fully sequenced, AAA   273/273
(100 %)
1 diff
(99.7 %id)
W72010 heart .a 3160 to 3430 278 to 1       278/289
(96 %)
17 diff
(94.2 %id)
W57815 heart .a 3161 to 3431 273 to 1       273/273
(100 %)
4 diff
(98.6 %id)
BG223332 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 3167 to 3433 268 to 1       268/268
(100 %)
4 diff
(98.6 %id)
W32424 parathyroid gland, parathyroid tumor .a 3168 to 3431 283 to 13   fully sequenced, AAA   271/271
(100 %)
2 diff
(99.3 %id)
BU731610 eye, RPE and Choroid .a 3172 to 3430 278 to 20   fully sequenced, AAA   259/259
(100 %)
0 diff
(100 %id)
AI500082 lymph node, lymphoma, follicular mixed small and largecell .a 3188 to 3431 265 to 27   AAA   239/247
(96 %)
7 diff
(97.2 %id)
R73111 breast .a 3196 to 3423 236 to 8       229/236
(97 %)
2 diff
(99.2 %id)
AA910571 pooled germ cell tumors .a 3201 to 3392 193 to 2       192/193
(99 %)
0 diff
(100 %id)
AW438929 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3213 to 3431 236 to 16   AAA   221/221
(100 %)
5 diff
(97.8 %id)
AA147879 uterus .a 3219 to 3435 209 to 1   fully sequenced,   209/209
(100 %)
0 diff
(100 %id)
H42474 breast .a 3222 to 3426 206 to 1   fully sequenced,   206/206
(100 %)
0 diff
(100 %id)
W58668 heart .a 3248 to 3428 188 to 1   fully sequenced,   188/188
(100 %)
2 diff
(99.0 %id)
AA536116 invasive prostate tumor, Prostate .a 3253 to 3431 1 to 179   AAA   179/179
(100 %)
6 diff
(96.7 %id)
D19805   .a 3269 to 3438 1 to 170     Submitted on the opposite strand 170/173
(98 %)
1 diff
(99.5 %id)
CX780977 human embryonic stem cells .a 3305 to 3428 159 to 36   AAA   124/127
(97 %)
0 diff
(100 %id)
BM508250 insulinoma, Pancreas .a 3317 to 3431 137 to 23   AAA   115/179
(64 %)
0 diff
(100 %id)
AF086502   .a 3386 to 3986 601 to 1   tiling clone, Submitted on the opposite strand 601/610
(98 %)
0 diff
(100 %id)
W95358 heart .a 3387 to 3779 1 to 397     Submitted on the opposite strand 397/398
(99 %)
5 diff
(98.8 %id)
W95357 heart .a 3629 to 3986 361 to 2     Submitted on the opposite strand 360/361
(99 %)
0 diff
(100 %id)
CR986718 T-Lymphocytes .b 1 to 775 1 to 776   tiling clone,   776/776
(100 %)
2 diff
(99.8 %id)
CK000224 mixed .b 122 to 887 13 to 778       766/790
(96 %)
5 diff
(99.4 %id)
CN430384 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 249 to 1000 1 to 751   tiling clone,   751/751
(100 %)
4 diff
(99.5 %id)
BU859034 ovary, teratocarcinoma, cell line .c 1 to 887 1 to 891   tiling clone,   889/896
(99 %)
13 diff
(98.6 %id)
CN430389 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 783 to 1150 1 to 368   tiling clone,   368/368
(100 %)
0 diff
(100 %id)
U62794   .d 1 to 1377 1 to 1377 exact tiling clone,   1377/1378
(99 %)
4 diff
(99.8 %id)
AL533421 adult brain, brain .e 1 to 847 1 to 848 P3X D40X E74R V75G A76G ... tiling clone,   848/848
(100 %)
6 diff
(99.3 %id)
AK310605 thymus .f 1 to 920 1 to 920 exact tiling clone,   920/920
(100 %)
0 diff
(100 %id)
DB127091 thymus .f 2 to 555 2 to 555 exact capped   554/554
(100 %)
0 diff
(100 %id)
DB128462 thymus .f 16 to 520 2 to 507 L23P K24E L25A A26G S27L ... capped   506/506
(100 %)
1 diff
(99.9 %id)
BE297239 muscle, rhabdomyosarcoma .f 377 to 917 1 to 541       541/541
(100 %)
0 diff
(100 %id)
BF893519 marrow .g-u 1 to 499 503 to 6   tiling clone, Submitted on the opposite strand 498/503
(99 %)
0 diff
(100 %id)
BX484430   .g-u 446 to 844 1 to 399   tiling clone,   399/399
(100 %)
1 diff
(99.8 %id)
CR978586 T-Lymphocytes .h 1 to 634 1 to 634 S89X L104X tiling clone,   634/634
(100 %)
0 diff
(100 %id)
DA284493 corpus callosum .i 1 to 543 25 to 570   tiling clone, capped   546/569
(95 %)
0 diff
(100 %id)
DA139967 alzheimer cortex .i 116 to 680 2 to 566 exact tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
CN276500 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j-u 1 to 696 1 to 696 exact tiling clone,   696/696
(100 %)
0 diff
(100 %id)
CA395706 eye, RPE/choroid .k 1 to 500 1 to 500 G106W tiling clone,   500/500
(100 %)
1 diff
(99.8 %id)
DA965043 stomach .l 1 to 579 2 to 580 exact tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
DA969519 stomach .l 5 to 567 2 to 564 exact capped   563/563
(100 %)
0 diff
(100 %id)
AK307296 Spleen .l 18 to 918 1 to 901 exact     901/901
(100 %)
0 diff
(100 %id)
DA949371 Spleen .l 19 to 574 2 to 557 exact capped   556/556
(100 %)
0 diff
(100 %id)
BP356009   .l 20 to 585 1 to 573 G106X     573/583
(98 %)
8 diff
(98.7 %id)
DA988308 synovial membrane tissue from rheumatioidarthritis .l 23 to 474 2 to 453 exact capped   452/452
(100 %)
0 diff
(100 %id)
DA382178 thalamus .l 40 to 599 2 to 561 exact capped   560/560
(100 %)
0 diff
(100 %id)
CV573431 cornea, eye .l 58 to 559 1 to 502 exact     502/502
(100 %)
0 diff
(100 %id)
DR422897 eye, Pterygium .l 173 to 947 1 to 775   tiling clone,   775/775
(100 %)
6 diff
(99.3 %id)
T85750 liver and spleen .l 596 to 905 1 to 314       314/314
(100 %)
4 diff
(98.8 %id)
CV333330 marrow .l 792 to 1133 342 to 1   tiling clone, Submitted on the opposite strand 342/342
(100 %)
8 diff
(97.7 %id)
CR745633 heart .l 1060 to 1509 1 to 451   tiling clone,   451/454
(99 %)
4 diff
(99.2 %id)
BQ269196 Pancreas, Purified pancreatic islet .l 1085 to 1600 1 to 516       516/516
(100 %)
2 diff
(99.7 %id)
AA234694 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 1091 to 1581 1 to 491   tiling clone, fully sequenced,   491/491
(100 %)
1 diff
(99.8 %id)
CK825689 Pancreas, Purified pancreatic islet .l 1091 to 1638 1 to 548     Submitted on the opposite strand 548/548
(100 %)
1 diff
(99.9 %id)
BQ710686 Spleen .l 1230 to 2077 1 to 855   tiling clone,   855/855
(100 %)
9 diff
(99.0 %id)
BQ711777 Spleen .l 1230 to 2032 1 to 814   tiling clone,   814/886
(91 %)
17 diff
(98.1 %id)
AW973682   .l 1298 to 1861 559 to 1     Submitted on the opposite strand 559/559
(100 %)
7 diff
(98.8 %id)
BQ268923 Pancreas, Purified pancreatic islet .l 1364 to 1861 498 to 1       498/498
(100 %)
3 diff
(99.4 %id)
CK825690 Pancreas, Purified pancreatic islet .l 1401 to 1800 400 to 1     Submitted on the opposite strand 400/400
(100 %)
2 diff
(99.5 %id)
AA709154 heart .l 1413 to 1863 451 to 1       451/451
(100 %)
6 diff
(98.7 %id)
AI366756 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 1424 to 1862 439 to 1       439/439
(100 %)
4 diff
(99.1 %id)
AA554182 breast .l 1475 to 1862 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
AA234102 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 1551 to 1862 312 to 1   fully sequenced,   312/312
(100 %)
1 diff
(99.7 %id)
BY795338 eye .m-u 1 to 629 1 to 629   tiling clone,   629/629
(100 %)
1 diff
(99.9 %id)
BE045559 carcinoid, lung .m-u 208 to 685 1 to 478 D42N tiling clone, Submitted on the opposite strand 478/478
(100 %)
5 diff
(99.0 %id)
AW612092 carcinoid, lung .m-u 208 to 561 1 to 355     Submitted on the opposite strand 355/355
(100 %)
5 diff
(98.6 %id)
BF933655 nervous_tumor .m-u 322 to 624 1 to 303       303/311
(97 %)
2 diff
(99.4 %id)
CB850951 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene ARHGAP1, variant not shown       AAA This clone was ignored    
AK126404 uterus Gene ARHGAP1, variant not shown       available from FLJ, This clone was ignored    
FN100802 breast carcinoma Gene ARHGAP1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BG216270   Gene ARHGAP1, variant not shown         Submitted on the opposite strand    
DB262054 uterus Gene ARHGAP1, variant not shown       capped This clone was ignored    
DB351691 uterus Gene ARHGAP1, variant not shown         This clone was ignored    
AK298562   Gene ARHGAP1, variant not shown         Suspected internal deletion, this clone was ignored    
AI816928 2 pooled tumors (clear cell type), Kidney Gene ARHGAP1, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
AW071973 anaplastic oligodendroglioma, brain Gene ARHGAP1, variant not shown         This clone was ignored    
BG679839 skin, squamous cell carcinoma Gene ARHGAP1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_149302171   Gene ARHGAP1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j-u, .k, .l, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI